Fely, Biaco D.
HRN: 20-59-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
CEFUROXIME 1.5GM (VIAL)
03/24/2023
03/24/2023
IVTT
1.5g
Now
OR Prophylaxis For CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes